The effect of different types of storage solutions on saphenous vein endothelial integrity in diabetic patients undergoing coronary artery bypass grafting-Reference-Cited by-同舟云学术

The effect of different types of storage solutions on saphenous vein endothelial integrity in diabetic patients undergoing coronary artery bypass grafting

Published:2023 Issue:12 Volume:80 Page:1008-1015
ISSN:0042-8450
Container-title:Vojnosanitetski pregled
language:en
Short-container-title:VOJNOSANIT PREGL

Author:

Kamenov Aleksandar¹^ORCID,Stojiljkovic Vladimir¹,Petrovic Aleksandar²,Lazarevic Milan¹^ORCID,Golubovic Mladjan¹,Peric Velimir¹,Stosic Marija¹^ORCID,Radenkovic Goran²^ORCID,Nikolic Ivan²,Petrovic Vladimir²,Zivic Sasa¹,Milic Dragan¹

Affiliation:

1. University Clinical Center Niš, Cardiac Surgery Clinic, Niš, Serbia

2. University of Niš, Faculty of Medicine, Department of Histology and Embryology, Niš, Serbia

Abstract

Background/Aim. Taking into consideration the justified popularity of total arterial revascularization, the saphenous vein graft (SVG) is still one of the most utilized conduits in coronary artery bypass grafting (CABG). One of the determining factors of this conduit?s durability is its endothelial integrity at the time of surgery. The aim of the study was to investigate the effect of different storage solutions on SVG endothelial integrity in patients with diabetes mellitus (DM) type 2 (T2DM) and non-T2DM patients undergoing CABG. The solutions under evaluation were heparinized saline solution (0.9% NaCl), heparinized autologous whole blood, Bretschneider (histidine-tryptophan-ketoglutarate ? HTK) solution, and fresh frozen plasma (FFP) solution. Methods. Forty patients were included in this study and were divided into two groups: group A with 23 T2DM patients and group B with 17 non-T2DM patients. The effects of these solutions were examined by immunohistochemical staining with anti-CD34 antibodies and morphometric comparison in histologic samples of T2DM patients undergoing CABG between July 2021 and September 2022 with samples provided by non-T2DM patients. Results. In this study, the FFP solution showed the most prominent positive effect on the preservation of SVG endothelial integrity, with an average cell integrity preservation of 92.2%. HTK solution was found to be the least effective, with an endothelial cell preservation integrity of 26.77%. There was no marked statistically significant difference in results from groups A and B. There was a noticeable contrast in preserving SVG endothelial integrity between the two patient groups, T2DM and non-T2DM patients, although it was not statistically significant. Conclusion. The storage solution with the most beneficial effect on SVG endothelial integrity preservation was the FFP solution when harvested via the conventional open method in CABG.

Publisher

National Library of Serbia

Subject

Pharmacology (medical)

Reference25 articles.

1. Barquera S, Pedroza-Tobías A, Medina C, Hernández-Barrera L, Bibbins-Domingo K, Lozano R, et al. Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch Med Res 2015; 46(5): 328-38.

2. Ruttmann E, Fischler N, Sakic A, Chevtchik O, Alber H, Schistek R, et al. Second Internal Thoracic Artery Versus Radial Artery in Coronary Artery Bypass Grafting: a long-term, propensity score-matched follow-up study. Circulation 2011; 124(12): 1321-9.

3. Melly L, Torregrossa G, Lee T, Jansens JL, Puskas JD. Fifty years of coronary artery bypass grafting. J Thorac Dis 2018; 10(3): 1960-7.

4. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004; 44(11): 2149-56.

5. Brilakis ES, Rao SV, Banerjee S, Goldman S, Shunk KA, Holmes DR, et al. Percutaneous Coronary Intervention in Native Arteries Versus Bypass Grafts in Prior Coronary Artery Bypass Grafting Patients: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv 2011; 4(8): 844-50.